Safety Study of KHN707 Tablets in Healthy Adults
This is an early-stage safety study testing a new tablet called KHN707 in healthy volunteers. Researchers want to understand how the body processes the drug and check for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old
- Your weight must be at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female, with a healthy BMI between 19–26
- You must use effective birth control and not plan to donate sperm or eggs for 3 months after your last dose
- Your liver, kidney, and heart function must be normal based on blood tests and an ECG (heart rhythm test)
- You cannot have taken other medications (including vitamins and herbal products) for 2 weeks before the study starts
- You must avoid alcohol, caffeine, and smoking during the study, and agree to a simple diet provided by the research team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new drug called NHL907 in healthy volunteers. Researchers want to understand how the drug is processed by the body and confirm it is safe.
This trial tests a new tablet called KHN702 in healthy people to see how safe it is and how the body processes it. It helps researchers understand the right dose and any side effects before moving to larger studies.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.